Lactose (India) Limited (BOM:524202)

Market Cap	1.41B
Revenue (ttm)	1.27B
Net Income (ttm)	43.92M
Shares Out	12.59M
EPS (ttm)	3.43
PE Ratio	32.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,006
Average Volume	11,174
Open	116.53
Previous Close	115.96
Day's Range	112.10 - 120.00
52-Week Range	84.27 - 247.40
Beta	0.49
RSI	65.23
Earnings Date	Aug 12, 2025

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India. The company is involved in the production of drugs, medicines, chemicals, foods, etc. It offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in solid dose forms. In addition, the company provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver dis...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 129
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524202

Financial Performance

In 2024, Lactose (India)'s revenue was 1.16 billion, an increase of 2.20% compared to the previous year's 1.14 billion. Earnings were 51.63 million, a decrease of -23.95%.